Cachet Pharmaceutical Past Earnings Performance
Past criteria checks 1/6
Cachet Pharmaceutical's earnings have been declining at an average annual rate of -5%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 8.1% per year. Cachet Pharmaceutical's return on equity is 6.4%, and it has net margins of 0.8%.
Key information
-5.0%
Earnings growth rate
-7.7%
EPS growth rate
Healthcare Industry Growth | 7.0% |
Revenue growth rate | 8.1% |
Return on equity | 6.4% |
Net Margin | 0.8% |
Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How Cachet Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 30,683 | 258 | 995 | 0 |
31 Dec 23 | 29,996 | 250 | 1,052 | 0 |
30 Sep 23 | 27,727 | 287 | 1,254 | -3 |
30 Jun 23 | 28,391 | 283 | 1,239 | -2 |
31 Mar 23 | 26,515 | 286 | 1,214 | -1 |
31 Dec 22 | 26,220 | 297 | 1,227 | 0 |
30 Sep 22 | 26,555 | 335 | 1,116 | 3 |
30 Jun 22 | 25,770 | 348 | 1,180 | 2 |
31 Mar 22 | 26,276 | 351 | 1,156 | 1 |
31 Dec 21 | 25,626 | 354 | 1,115 | 0 |
30 Sep 21 | 26,318 | 338 | 985 | 0 |
30 Jun 21 | 26,106 | 357 | 1,031 | 0 |
31 Mar 21 | 25,018 | 348 | 1,012 | 0 |
31 Dec 20 | 23,256 | 318 | 957 | 0 |
30 Sep 20 | 22,670 | 325 | 1,193 | 0 |
30 Jun 20 | 21,660 | 300 | 1,136 | 0 |
31 Mar 20 | 21,396 | 328 | 1,123 | 0 |
31 Dec 19 | 22,187 | 376 | 1,148 | 0 |
30 Sep 19 | 20,601 | 363 | 1,090 | 0 |
30 Jun 19 | 19,679 | 354 | 979 | 0 |
31 Mar 19 | 19,011 | 339 | 936 | 0 |
31 Dec 18 | 17,960 | 328 | 855 | 0 |
30 Sep 18 | 17,181 | 323 | 766 | 0 |
30 Jun 18 | 16,223 | 306 | 684 | 0 |
31 Mar 18 | 14,997 | 280 | 642 | 0 |
31 Dec 17 | 14,239 | 264 | 624 | 0 |
30 Sep 17 | 13,270 | 253 | 571 | 0 |
30 Jun 17 | 12,395 | 250 | 557 | 0 |
31 Mar 17 | 11,578 | 240 | 544 | 0 |
31 Dec 16 | 10,972 | 223 | 545 | 0 |
30 Sep 16 | 10,320 | 211 | 555 | 0 |
30 Jun 16 | 9,628 | 199 | 576 | 0 |
31 Mar 16 | 8,922 | 189 | 570 | 0 |
31 Dec 15 | 8,200 | 173 | 550 | 0 |
30 Sep 15 | 7,540 | 166 | 525 | 0 |
30 Jun 15 | 6,871 | 158 | 495 | 0 |
31 Mar 15 | 6,188 | 142 | 448 | 0 |
31 Dec 14 | 5,572 | 228 | 401 | 0 |
30 Sep 14 | 4,976 | 243 | 331 | 0 |
30 Jun 14 | 4,342 | 231 | 277 | 0 |
31 Mar 14 | 3,907 | 236 | 223 | 0 |
31 Dec 13 | 3,544 | 130 | 195 | 0 |
30 Sep 13 | 3,124 | 89 | 155 | 0 |
30 Jun 13 | 2,926 | 85 | 145 | 0 |
Quality Earnings: 002462 has high quality earnings.
Growing Profit Margin: 002462's current net profit margins (0.8%) are lower than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002462's earnings have declined by 5% per year over the past 5 years.
Accelerating Growth: 002462's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002462 had negative earnings growth (-9.8%) over the past year, making it difficult to compare to the Healthcare industry average (-1%).
Return on Equity
High ROE: 002462's Return on Equity (6.4%) is considered low.